Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply
- PMID: 33368507
- DOI: 10.1111/apt.16213
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply
Comment on
-
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.Aliment Pharmacol Ther. 2021 Jan;53(2):273-280. doi: 10.1111/apt.16167. Epub 2020 Nov 18. Aliment Pharmacol Ther. 2021. PMID: 33210332
-
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD?Aliment Pharmacol Ther. 2021 Jan;53(2):346-347. doi: 10.1111/apt.16186. Aliment Pharmacol Ther. 2021. PMID: 33368516 No abstract available.
Similar articles
-
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD?Aliment Pharmacol Ther. 2021 Jan;53(2):346-347. doi: 10.1111/apt.16186. Aliment Pharmacol Ther. 2021. PMID: 33368516 No abstract available.
-
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients.Aliment Pharmacol Ther. 2021 Jan;53(2):273-280. doi: 10.1111/apt.16167. Epub 2020 Nov 18. Aliment Pharmacol Ther. 2021. PMID: 33210332
-
Editorial: serum triiodothyronine-to-thyroxine (T3/T4) ratio as biomarker of response in IBD - an open issue.Aliment Pharmacol Ther. 2022 Sep;56(5):903-904. doi: 10.1111/apt.17136. Aliment Pharmacol Ther. 2022. PMID: 35934852 No abstract available.
-
Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism.Nucl Med Commun. 2009 Aug;30(8):586-93. doi: 10.1097/MNM.0b013e32832c79e0. Nucl Med Commun. 2009. PMID: 19491714
-
[Croatian consensus on the treatment of inflammatory bowel diseases with biologic therapy].Acta Med Croatica. 2013 Apr;67(2):75-87. Acta Med Croatica. 2013. PMID: 24471291 Croatian.
References
REFERENCES
-
- Carbery I, Selinger C. Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Aliment Pharmacol Ther. 2021;53:346-347.
-
- Bertani L, Tricò D, Pugliese D, et al. Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients. Aliment Pharmacol Ther. 2021;53:273-280.
-
- Maia AL, Goemann IM, Meyer EL, Wajner SM. Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease. J Endocrinol. 2011;209:283-297.
-
- Bamba S, Sasaki M, Takaoka A, et al. Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease. PLoS One. 2017;12:e0180036.
-
- Pasqualetti G, Calsolaro V, Bernardini S, et al. Degree of peripheral thyroxin deiodination, frailty, and long-term survival in hospitalized older patients. J Clin Endocrinol Metab. 2018;103:1867-1876.